-
Respiratory Illness Report: 11/2/24-11/9/24
Communicable Disease Data Report, COVID-19, Influenza, Respiratory Illness Report, Respiratory Illness ReportView this report as an interactive dashboard. In week ending November 9, local indicators for COVID-19, influenza, and respiratory syncytial virus (RSV) were minimal. Regional laboratory data have been most frequently detecting rhinovirus among clinical respiratory specimens. Elevated pertussis activity is also being reported throughout Washington State. Fewer than 10 emergency department (ED) visits were…
-
Kitsap Respiratory Illness Report: 10/27/24-11/2/24
Communicable Disease Data Report, COVID-19, Influenza, Respiratory Illness Report, Respiratory Illness ReportView this report as an interactive dashboard. In week ending November 2, local indicators for COVID-19 and respiratory syncytial virus (RSV) remained minimal. Influenza indicators remained low but showed signs that local flu activity is beginning to rise. Regional laboratory data are most frequently detecting rhinovirus among clinical respiratory specimens. 0.7% of emergency department (ED) visits were…
-
Health Advisory: Update on local pertussis activity
Advisory or Update, Communicable Disease and Immunization Update, Immunization, Immunizations, News and Alerts, News and Update, Notifiable Conditions, PertussisACTIONS REQUESTED BE AWARE of local pertussis activity and consider pertussis in patients exhibiting symptoms of respiratory illness. Diagnosing pertussis can be difficult, particularly during the early (catarrhal) stage of illness, which may present with non-specific symptoms and might not initially include a cough. Pertussis should be included in the differential diagnosis of patients with respiratory…
-
Kitsap Respiratory Illness Report: 10/20/24-10/26/24
Communicable Disease Data Report, COVID-19, Influenza, Respiratory Illness Report, Respiratory Illness ReportView this report as an interactive dashboard. In week ending October 26, local indicators for COVID-19, influenza and respiratory syncytial virus (RSV) remained minimal. 0.8% of emergency department (ED) visits were attributable to COVID-19, and fewer than 10 visits were attributable to either influenza or RSV. Kitsap sentinel reporting labs reported 24 positive COVID-19 tests (6.2% of specimens…
-
Kitsap Respiratory Illness Report: Oct. 13-19
Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Prevention, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportIn the week ending October 19, local indicators for COVID-19 showed a very low level of activity. Local indicators for influenza and respiratory syncytial virus (RSV) remained minimal. Fewer than 10 emergency department (ED) visits were attributable to COVID-19, influenza or RSV. Kitsap sentinel reporting labs reported 18 positive COVID-19 tests (3.8% of specimens tested), 12…
-
Health Advisory: Update on avian influenza in Kitsap and Washington
Advisory or Update, Health Advisory, Health Alert, Infection Control, News and Alerts, News and Update, Prevention, Provider ResourcesH5N1 highly pathogenic avian influenza (HPAI) has been confirmed by the Washington State Department of Agriculture on Oct. 18, 2024, in a backyard poultry flock in South Kitsap. There are currently no human cases associated with this flock. On October 20, 2024, the Washington State Department of Health (DOH) reported that four poultry workers in Franklin County tested presumptive…
-
Kitsap Respiratory Illness Report: Oct. 6-12
Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Prevention, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportIn week ending October 12, local indicators for COVID-19 showed low level of activity. Local indicators for influenza and respiratory syncytial virus (RSV) remained minimal. 1.3% of emergency department (ED) visits were attributable to COVID-19, and fewer than 10 visits were attributable to either influenza or RSV. Kitsap sentinel reporting labs reported 51 positive COVID-19 tests…
-
Kitsap Respiratory Illness Report: Sept. 29 – Oct. 5
Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Immunization, Influenza, Influenza Update, Respiratory Illness Report, Respiratory Illness ReportIn week ending October 5, local indicators for COVID-19 showed low level of activity. Local indicators for influenza and respiratory syncytial virus (RSV) remained minimal. 1.7% of emergency department (ED) visits were attributable to COVID-19, and fewer than 10 visits were attributable to either influenza or RSV. Kitsap sentinel reporting labs reported 47 positive COVID-19 tests…
-
Kitsap Respiratory Illness Report: Sept. 22-28
Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Prevention, Respiratory Illness Report, Respiratory Illness ReportIn the week ending September 28, local indicators for COVID-19 remained at elevated levels, and have generally remained steady since the end of June 2024. Local indicators for influenza and respiratory syncytial virus (RSV) remained minimal. 2.1% of emergency department (ED) visits were attributable to COVID-19, and fewer than 10 visits were attributable to either…
-
Health Advisory: 2024–2025 Respiratory Illness Season Vaccine Recommendations
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, Health Alert, Infection Control, Influenza, Influenza Update, News and Alerts, News and UpdateACTIONS REQUESTED BE AWARE that the CDC recommends everyone 6 months or older get 2024–2025 COVID-19 and flu vaccine. Co-administration of COVID-19, flu, and RSV vaccines is safe. BE AWARE that the CDC expects supplies of nirsevimab (Beyfortus) RSV monoclonal antibody for infants and young children to be adequate for the 2024–2025 season. REMIND patients that vaccination is one…
-
Kitsap Respiratory Illness Report: Aug. 18 to Sept. 14
Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Prevention, Provider Resources, Respiratory Illness Report, Respiratory Illness ReportIn the week ending September 14, local indicators for COVID-19 remained at elevated levels, which have more or less remained steady since the end of June 2024. Local indicators for influenza and respiratory syncytial virus (RSV) remained very low. 1.8% of emergency department (ED) visits were attributable to COVID-19, fewer than 10 visits were attributable to either influenza…
-
Health Advisory: 2024-2025 COVID-19 vaccines approved
ACTIONS REQUESTED BE AWARE that updated (2024–2025) COVID-19 vaccines have been approved and authorized by the FDA. The new formulations provide better protection against currently circulating COVID-19 variants. For more information, see: DISCONTINUE USE of the 2023–2024 Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines. These formulations are no longer authorized by the FDA. BE AWARE that there are two types…
-
Kitsap Respiratory Illness Report: July 21 to Aug. 17
Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Infection Control, Influenza, Influenza Update, News and Alerts, News and Update, Respiratory Illness Report, Respiratory Illness ReportIn the week ending July 20, local indicators for COVID-19 remained elevated, but appeared to be holding steady. Local indicators for influenza and respiratory syncytial virus (RSV) remained very low. 1.5% of emergency department visits were attributable to COVID-19, and fewer than 10 emergency department (ED) visits were attributable to either influenza or RSV. Kitsap sentinel…